Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines ; volume:17 ; number:1 ; day:13 ; month:1 ; year:2017 ; pages:1-15 ; date:12.2017
BMC cancer ; 17, Heft 1 (13.1.2017), 1-15, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ayyagari, Vijayalakshmi N.
- Beteiligte Personen und Organisationen
-
Hsieh, Tsung-han Jeff
Diaz-Sylvester, Paula L.
Brard, Laurent
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-3034-2
- URN
-
urn:nbn:de:1111-2017021029274
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ayyagari, Vijayalakshmi N.
- Hsieh, Tsung-han Jeff
- Diaz-Sylvester, Paula L.
- Brard, Laurent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytotoxicity of some synthetic bis(arylidene) derivatives of cyclic ketones towards cisplatin-resistant human ovarian carcinoma cells
Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Cytotoxicity of some synthetic bis(arylidene) derivatives of cyclic ketones towards cisplatin-resistant human ovarian carcinoma cells
Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Cytotoxicity of some synthetic bis(arylidene) derivatives of cyclic ketones towards cisplatin-resistant human ovarian carcinoma cells
Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer